Aegle Therapeutics Corp

Woburn, MA · Biotechnology

Aegle Therapeutics Corp is a biotechnology company based in Woburn, Massachusetts. In a Form D filed with the SEC on August 28, 2026, it reported raising $2,277,698 from 17 investors as part of an offering of up to $2,277,698. The first sale in the offering took place on August 4, 2026.

Amount raised: $2,277,698
Offering size: $2,277,698
Investors so far: 17
First sale: August 4, 2026
Securities offered: Equity
Exemption claimed: Rule 506(b)
Industry: Biotechnology
Headquarters: Woburn, Massachusetts
Incorporated: Delaware
Entity type: Corporation

Filings

Filed	Form	Raised	Offering size	Investors	Source
Aug 28, 2026	D (new notice)	$2,277,698	$2,277,698	17	SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Massachusetts

Company	Location	Sector	Raised	Target	Filed
Axelyf, Inc.	Chestnut Hill, MA	Health Care	$2.6M	$2.7M	Oct 13
Soterya, Inc.	Boston, MA	Health Care	$850K	$2M	Oct 13
Bioventrix, Inc.	Mansfield, MA	Health Care	$1.2M	$3M	Oct 8
Opus KSD, Inc.	Pembroke, MA	Health Care	$681K	$681K	Oct 1
Xact Bio, Inc.	Boston, MA	Health Care	$10M	$18M	Sep 28
Way Biosolutions, Inc.	Cambridge, MA	Health Care	$2M	$2M	Sep 25